Keywords: az, merck, co, develop, early-stage, cancer, drugs

AZ and Merck & Co to develop early-stage cancer drugs

Article | 02 June 2009

Print This

Anglo-Swedish drug major AstraZeneca and the USA's Merck & Co have signed an accord to develop a cocktail of cancer drugs ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in